This company listing is no longer active
NVIV.Q Overzicht aandelen
Operates as a research and clinical-stage biomaterials and biotechnology company in the United States.
Sneeuwvlok Score | |
---|---|
Waardering | 2/6 |
Toekomstige groei | 0/6 |
Prestaties in het verleden | 0/6 |
Financiële gezondheid | 4/6 |
Dividenden | 0/6 |
InVivo Therapeutics Holdings Corp. Concurrenten
Prijsgeschiedenis en prestaties
Historische aandelenkoersen | |
---|---|
Huidige aandelenkoers | US$0.37 |
52 Week Hoogtepunt | US$1.41 |
52 Week Laag | US$0.15 |
Bèta | 0.37 |
11 maand verandering | -7.38% |
3 maanden verandering | -0.87% |
1 Jaar Verandering | -71.54% |
33 jaar verandering | -97.73% |
5 jaar verandering | -99.92% |
Verandering sinds IPO | -100.00% |
Recent nieuws en updates
Recent updates
InVivo Therapeutics dips 24% on $9M direct and private placement offerings
Oct 07We're Not Very Worried About InVivo Therapeutics Holdings' (NASDAQ:NVIV) Cash Burn Rate
Aug 26Is InVivo Therapeutics Holdings (NASDAQ:NVIV) In A Good Position To Invest In Growth?
May 05Will InVivo Therapeutics Holdings (NASDAQ:NVIV) Spend Its Cash Wisely?
Jan 18Rendement voor aandeelhouders
NVIV.Q | US Medical Equipment | US Markt | |
---|---|---|---|
7D | -2.6% | -1.6% | -0.9% |
1Y | -71.5% | 32.6% | 38.9% |
Rendement versus industrie: NVIV.Q underperformed the US Medical Equipment industry which returned -3.1% over the past year.
Rendement versus markt: NVIV.Q underperformed the US Market which returned 22% over the past year.
Prijsvolatiliteit
NVIV.Q volatility | |
---|---|
NVIV.Q Average Weekly Movement | 8.7% |
Medical Equipment Industry Average Movement | 7.9% |
Market Average Movement | 6.1% |
10% most volatile stocks in US Market | 15.0% |
10% least volatile stocks in US Market | 3.0% |
Stabiele aandelenkoers: NVIV.Q's share price has been volatile over the past 3 months.
Volatiliteit in de loop van de tijd: NVIV.Q's weekly volatility has decreased from 26% to 9% over the past year.
Over het bedrijf
Opgericht | Werknemers | CEO | Website |
---|---|---|---|
2003 | 6 | Rich Toselli | www.invivotherapeutics.com |
InVivo Therapeutics Holdings Corp. Samenvatting
NVIV.Q fundamentele statistieken | |
---|---|
Marktkapitalisatie | US$1.15m |
Inkomsten(TTM) | -US$9.33m |
Inkomsten(TTM) | n/a |
0.0x
P/S-verhouding-0.1x
Koers/WinstverhoudingIs NVIV.Q overgewaardeerd?
Zie Reële waarde en waarderingsanalyseInkomsten en omzet
NVIV.Q resultatenrekening (TTM) | |
---|---|
Inkomsten | US$0 |
Kosten van inkomsten | US$0 |
Brutowinst | US$0 |
Overige uitgaven | US$9.33m |
Inkomsten | -US$9.33m |
Laatst gerapporteerde inkomsten
Sep 30, 2023
Volgende inkomensdatum
n.v.t.
Winst per aandeel (EPS) | -3.00 |
Brutomarge | 0.00% |
Nettowinstmarge | 0.00% |
Schuld/Eigen Vermogen Verhouding | 0% |
Hoe presteerde NVIV.Q op de lange termijn?
Bekijk historische prestaties en vergelijking